https://www.selleckchem.com/pr....oducts/pf-04965842.h
Dopamine receptor agonist drugs, which are used, for example, to treat Parkinson's disease (PD), increase the risk for impulse control disorders (ICDs), potentially resulting in devastating psychosocial consequences. It is unknown whether other drugs with dopaminergic properties also increase the risk for ICDs. This study assesses the disproportionality of reporting ICDs between drugs with dopaminergic properties and selected non-dopaminergic drugs. A case/non-case disproportionality analysis was performed, using data from VigiBase
Curtir
Comentario
Compartilhar
